Kane Hall Barry is now infusing Ocrevus, the first drug approved by the FDA for the treatment of primary progressive MS. Ocrevus is also approved for relapsing remitting MS, the more common form of the disease. Ocrevus is an “anti-CD20 monoclonal antibody.” That is to say Ocrevus targets components of your own immune system which, […]